These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17062887)

  • 1. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T; Fougner SL; Godang K; Schreiner T; Bollerslev J
    Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M; Daroszewski J; Medraś M; Zadrozna-Sliwka B
    J Bone Miner Metab; 2006; 24(1):72-8. PubMed ID: 16369902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
    Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
    Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential presentation of cortical and trabecular peripheral bone mineral density in acromegaly.
    Jockenhövel F; Rohrbach S; Deggerich S; Reinwein D; Reiners C
    Eur J Med Res; 1996 May; 1(8):377-82. PubMed ID: 9360937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
    Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly.
    Bolanowski M; Jedrzejuk D; Milewicz A; Arkowska A
    Osteoporos Int; 2002; 13(4):303-8. PubMed ID: 12030545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
    Scillitani A; Battista C; Chiodini I; Carnevale V; Fusilli S; Ciccarelli E; Terzolo M; Oppizzi G; Arosio M; Gasperi M; Arnaldi G; Colao A; Baldelli R; Ghiggi MR; Gaia D; Di Somma C; Trischitta V; Liuzzi A
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal status is an important determinant of bone density in acromegaly.
    Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of high serum growth hormone and IGF-1 levels on bone mineral density in acromegaly.
    Tuzcu S; Durmaz ŞA; Carlıoğlu A; Demircan Z; Tuzcu A; Beyaz C; Tay A
    Z Rheumatol; 2017 Oct; 76(8):716-722. PubMed ID: 27766418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with bone metabolism in acromegalic patients: hypogonadism and female gender.
    Tütüncü NB; Erbaş T
    Exp Clin Endocrinol Diabetes; 2004 Jun; 112(6):328-32. PubMed ID: 15216451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal.
    Parkinson C; Kassem M; Heickendorff L; Flyvbjerg A; Trainer PJ
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5650-5. PubMed ID: 14671148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density of the axial skeleton in acromegaly.
    Ho PJ; Fig LM; Barkan AL; Shapiro B
    J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal volumetric trabecular bone mass in acromegalic patients: a longitudinal study.
    Battista C; Chiodini I; Muscarella S; Guglielmi G; Mascia ML; Carnevale V; Scillitani A
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):378-82. PubMed ID: 18616713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical assessment of bone formation and resorption in acromegaly.
    Ezzat S; Melmed S; Endres D; Eyre DR; Singer FR
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1452-7. PubMed ID: 8501150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly.
    Bolanowski M; Daroszewski J; Zatonska K; Arkowska A
    Neuro Endocrinol Lett; 2006; 27(1-2):183-8. PubMed ID: 16648806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.